Latest Stock Split Details
Key information about Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's most recent stock split
Split Date: 2022-07-11
Split Ratio: 13:10
Price Before Split: $27.16
Price After Split: $20.89
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.30 times more shares (a 13:10 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-07-11 | 13:10 | No | $27.16 | $20.89 |
| 2021-07-15 | 13:10 | No | $39.72 | $30.55 |
| 2020-07-23 | 13:10 | No | $62.13 | $47.79 |
| 2019-07-10 | 13:10 | No | $34.33 | $26.41 |
| 2018-04-03 | 13:10 | No | $34.38 | $26.45 |
About Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
Company overview and industry information
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 13-for-10 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Summary